Korean startups ILIAS Biologics and HK inno.N join hands for new biomedicines

Drug Discovery |  News | 0 Comment | 06 Jun, 2022

South Korean startup ILIAS Biologics has signed a Memorandum of Understanding (MoU) with HK inno.N for joint research to...Read more

Japanese startup LUCA Science raises $30.3 M in Series B funding

Drug Discovery |  News | 0 Comment | 06 Jun, 2022

Japan-based startup LUCA Science, a global innovator in the development of a novel class of mitochondria biopharmaceutic...Read more

Standigm signs MOU with Merck Korea for AI drug discovery research

Drug Discovery |  News | 0 Comment | 02 Jun, 2022

South Korea-based startup Standigm Inc. has announced the signing of a Memorandum of Understanding (MoU) with Merck Kore...Read more

China's Zelixir Biotech predicts monkeypox protein structures for drug discovery

Drug Discovery |  News | 0 Comment | 31 May, 2022

Zelixir Biotech, based in China, has predicted more than 600 structures and added functional annotations of proteins fro...Read more

Insilico Medicine explores use of 3CL protease inhibitor for COVID-19 treatment

Drug Discovery |  News | 0 Comment | 25 May, 2022

Insilico Medicine, a China & US-based clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery c...Read more

Japanese firms initiate joint research on next-gen IT drug discovery technology

Drug Discovery |  News | 0 Comment | 17 May, 2022

Japan-based Fujitsu and RIKEN have launched a joint research project on next-generation IT drug discovery technology uti...Read more

University of Tokyo, Astellas further advance development of innovative medicines

Drug Discovery |  News | 0 Comment | 27 Apr, 2022

The University of Tokyo and Astellas Pharma Inc., in Japan, have entered the second phase of their collaboration for co-...Read more

FDA grants Fast Track designation for Paradigm Biopharmaceuticals Phase III Osteoarthritis Program

Drug Discovery |  News | 0 Comment | 14 Apr, 2022

Australia's Paradigm Biopharmaceuticals, a clinical stage biopharmaceutical company focused on repurposing existing...Read more

TauRx's late-stage clinical trial reaches new milestone

Drug Discovery |  News | 0 Comment | 14 Apr, 2022

TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer's Disease (AD) research, has announced that the last p...Read more

Otsuka and Akebia seek USFDA approval for renal anemia drug

Drug Discovery |  News | 0 Comment | 01 Apr, 2022

Otsuka Pharmaceutical has announced that its collaborator Akebia Therapeutics, Inc. (Akebia) has submitted a New Drug Ap...Read more

Insilico Medicine partners with EQRx for AI-driven drug discovery

Drug Discovery |  News | 0 Comment | 25 Mar, 2022

Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, has entered i...Read more

Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments

Drug Discovery |  News | 0 Comment | 21 Mar, 2022

Biogen Inc. and Eisai Co., Ltd. announced that the companies have amended their existing collaboration agreement on aduc...Read more

RedHill inks deal worth $6M with Kukbo for COVID-19 drug in South Korea

Drug Discovery |  News | 0 Comment | 16 Mar, 2022

RedHill Biopharma has entered into an exclusive license agreement with Kukbo Co., a South Korean corporation, for o...Read more

Astellas’ menopause drug fails in Asia trial

Drug Discovery |  News | 0 Comment | 16 Mar, 2022

Japan-based Astellas Pharma Inc. has announced topline results from the ongoing Phase 3 MOONLIGHT 1 clinical trial inves...Read more

China approves SCG's T Cell Therapy IND to treat Hepatitis B virus

Drug Discovery |  News | 0 Comment | 14 Mar, 2022

Singapore-based SCG Cell Therapy Pte Ltd, a leading biotechnology company,  announced that the China National Medic...Read more

China's Gan & Lee Pharma begins first-in-human trial for diabetes drug

Drug Discovery |  News | 0 Comment | 11 Mar, 2022

Chinese firm Gan & Lee Pharmaceuticals has announced that the first subject has been dosed in our Phase I, double-bl...Read more

Dr Andreas Amrein joins Advanced Clinical to lead global development and expansion in APAC

Drug Discovery |  News | 0 Comment | 10 Mar, 2022

Advanced Clinical, a clinical development and strategic resourcing organization committed to providing a better clinical...Read more

China approves phase II trial of Akeso's cancer drug

Drug Discovery |  News | 0 Comment | 08 Mar, 2022

Akeso, Inc., a biopharmaceutical company dedicated to the development of innovative antibody drugs, has announced that t...Read more